Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Treatment of latent tuberculous infection in children and adolescent

소아청소년기 잠복결핵 감염의 치료

  • Kim, Jong-Hyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
  • 김종현 (가톨릭대학교 의과대학 소아과학교실)
  • Received : 2009.04.07
  • Accepted : 2009.04.09
  • Published : 2009.05.15
Download PDF
⟨ Previous Next ⟩

Abstract

Tuberculosis continues to cause an unacceptably high toll of disease and death among children worldwide. Whereas intense scientific and clinical research efforts into novel diagnostic, therapeutic, and preventive interventions have focused on tuberculosis in adults, childhood tuberculosis has been relatively neglected. However, children are particularly vulnerable to severe disease and death following infection, and those with latent infection become the reservoir for future transmission following disease reactivation in adulthood, fuelling future epidemics. Therefore, it is very important to understand the significance, diagnosis and treatment of latent tuberculous infection to decrease a future disease burden of tuberculosis. Unfortunately, these concept still have not fully implicated in Korean National Tuberculosis Control Program, it should be engaged and enforced as soon as possible.

결핵은 아직도 전세계적으로 소아에서 높은 유병률과 사망률을 보이는 질환이다. 아쉽게도 결핵에 대한 새로운 진단법, 치료법, 예방법에 대한 과학적 혹은 임상 연구는 주로 성인에 초점을 맞추어 왔으며 소아 결핵은 상대적으로 등한시되어 왔다. 그러나 특히 소아 결핵은 감염 후 중한 질환으로 진행되기 쉬우며 이는 사망을 초래하기도 한다. 또한 소아청소년기의 잠복결핵 감염은 후일 결핵균의 재활성으로 인하여 미래의 감염원으로 작용한다. 따라서 미래의 결핵 발생을 줄이기 위해서는 잠복결핵 감염에 대한 특징, 진단, 치료에 대해 이해하는 것이 매우 중요한다. 그러나 우리나라의 국가 결핵관리정책에는 이러한 개념들이 완전히 적용되지 않았으므로, 가능한 빨리 포함되고 시행되어져야 한다.

Keywords

References

  1. Kim JH. Evaluation for the usefulness of BCG vaccine: a survey for prevalence change of disseminated tuberculosis in children. Seoul: Korea Food and Drug Administration, 2007:42-6
  2. Korean Center for Disease Control and Prevention, Korean Institute of Tuberculosis. Annual report on the tuberculosis notified cases in Korea, 2005. Seoul: Division of AIDS & Tuberculosis, Korean Center for Disease Control and Prevention; Korean Institute of Tuberculosis. 2006:11-26
  3. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(RR-6):1-51
  4. Centers for Disease Control and Prevention. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR 2005;54(RR-12):1-81
  5. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London : Royal College of Physicians, 2006:105-16
  6. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB Gold Test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54(RR-15):49-55
  7. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006;6:413-22 https://doi.org/10.1586/14737159.6.3.413
  8. Starke JR. New concepts in childhood tuberculosis. Curr Opin Pediatr 2007;19:306-13 https://doi.org/10.1097/MOP.0b013e32814b164a
  9. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204
  10. Rigaud M. Borkowsky W. Tuberculosis in children. In : Rom WN, Garay SM, eds. Tuberculosis. 2nd ed. Philadelphia, PA : Lippincott Williams & Wilkins Co, 2004:607-24
  11. Starke JR, Smith KC. Tuberculosis. In : Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA : Saunders Co, 2004:1337-79
  12. Munoz FM, Starke JR. Tuberculosis. In : Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, PA : Saunders Co, 2004:958-72
  13. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-99 https://doi.org/10.1016/S0140-6736(03)14333-4
  14. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95 https://doi.org/10.1164/ajrccm.161.4.16141
  15. Grzybowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc 1975; 50:90-106
  16. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353:444-9 https://doi.org/10.1016/S0140-6736(98)03406-0
  17. Rose CE Jr, Zerbe GO, Lantz SO, Bailey WC. Establishing priority during investigation of tuberculosis contacts. Am Rev Respir Dis 1979;119:6039
  18. Fine PE. BCG: the challenge continues. Scand J Infect Dis 2001;33:243-5 https://doi.org/10.1080/003655401300077144
  19. Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun 2001;69:4195-201 https://doi.org/10.1128/IAI.69.7.4195-4201.2001
  20. Genewein A, Telenti A, Bernasconi C, Mordasini C, Weiss S, Maurer AM, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993;342:841-4 https://doi.org/10.1016/0140-6736(93)92698-S
  21. Kato-Maeda M, Bifani PJ, Kreiswirth BN, Small PM. The nature and consequence of genetic variability within Mycobacterium tuberculosis. J Clin Invest 2001;107:533-7 https://doi.org/10.1172/JCI11426
  22. del Castillo Otero D, Pe$\tilde{n}$afiel Col$\acute{a}$s M, Alvarez Guti$\acute{e}$rrez F, Soto Campos JG, Calder$\acute{o}$n Osuna E, Toral Marín J, et al. Investigation of tuberculosis contacts in a nonhospital pneumology practice. Eur J Clin Microbiol Infect Dis 1999; 18:790-5 https://doi.org/10.1007/s100960050402
  23. Ellner JJ. Review: the immune response in human tuberculosis - implications for tuberculosis control. J Infect Dis 1997;176:1351-9 https://doi.org/10.1086/514132
  24. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, et al. The natural history of childhood intra- thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:392-402
  25. Nelson LJ, Jereb JA, Castro KG. New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancement. Pediatrics 2004;114:1084-6 https://doi.org/10.1542/peds.2004-1525
  26. Bahceciler NN, Nuhoglu Y, Nursoy MA, Kodalli N, Barlan IB, Basaran MM. Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children. Pediatr Infect Dis J 2000;19:215-8
  27. Grzybowski, S, Fishault H, Rowe J, Brown A. Tuberculosis Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006;10:1192-204among patients with various radiologic abnormalities followed by the chest clinic service. Am Rev Respir Dis 1971; 104:605-8
  28. American Academy of Pediatrics. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Illinois : American Academy of Pediatrics, 2006:678-98
  29. Bouros D, Zeros G, Panaretos C, Vassilatos C, Siafakas N. Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest 1991;99:416-9 https://doi.org/10.1378/chest.99.2.416
  30. Bass JB Jr, Serio RA. The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1981;123:394-6
  31. Menzies D. Interpretation of repeated tuberculin tests. Am J Respir Crit Care Med 1991;159:15-21
  32. Hoskyns W. Paediatric tuberculosis. Postgrad Med J 2003; 79:272-8 https://doi.org/10.1136/pmj.79.931.272
  33. Steiner P, Rao M, Victoria MS, Jabbar H, Steiner M. Persistently negative tuberculin reactions: their presence among children with culture positive for Mycobacterium tuberculosis (tuberculin-negative tuberculosis). Am J Dis Child 1980;134: 747-50
  34. Starr S, Berkovich S. Effects of measles, gamma-globulin- modified measles and vaccine measles on the tuberculin test. N Engl J Med 1964;270:386-91 https://doi.org/10.1056/NEJM196402202700802
  35. Belsey MA. Tuberculosis and varicella infections in children. Am J Dis Child 1967;113:444-8
  36. Brickman HF, Beaudry PH, Marks MI. The timing of tuberculin tests in relation to immunization with live viral vaccines. Pediatrics 1975;55:392-6
  37. Bovornkitti S, Kangsadal P, Sathirapat P, Oonsombatti P. Reversion and reconversion rate of tuberculin skin reactions in correlation with the use of prednisone. Dis Chest 1960;38: 51-5 https://doi.org/10.1378/chest.38.1.51
  38. MacGregor RR, Sheagren JN, Lipsett MB, Wolff SM. Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects. N Engl J Med 1969;280:1427-31 https://doi.org/10.1056/NEJM196906262802601
  39. Fine PEM, Sterne JAC, Ponnighaus JM, Rees RJ. Delayed type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994;344:1245-9 https://doi.org/10.1016/S0140-6736(94)90748-X
  40. Menzies D. What does tuberculin reactivity after bacille Calmette-Gurin vaccination tell us? Clin Infect Dis 2000;31 Suppl 3:S71-4 https://doi.org/10.1086/314075
  41. Liffschitz M. The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics 1964;36:624-7
  42. Menzies R, Vissandjee B. Effect of bacille Calmette-Gurin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;141:621-5
  43. Chee CB, Soh CH, Boudville IC, Chor SS, Wang YT. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med 2001;164:958-61 https://doi.org/10.1164/ajrccm.164.6.2101093
  44. Canadian Medical Association. Canadian Immu 6th ed. Ottawa:Authority of the Minister of Health, 2002: 71-6
  45. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54 https://doi.org/10.7326/0003-4819-146-5-200703060-00006
  46. Davies PDO, Drobniewski F. The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection. Eur Respir J 2006;28:1-3 https://doi.org/10.1183/09031936.06.00047606
  47. Nolan CM, Elarth AM. Tuberculosis in a cohort of Southeast Asian Refugees. A five-year surveillance study. Am Rev Respir Dis 1988;137:805-9 https://doi.org/10.1164/ajrccm/137.4.805
  48. Machado A Jr, Emodi K, Takenami I, Finkmoore BC, Barbosa T, Carvalho J, et al. Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. Int J Tuberc Lung Dis 2009;13:446-53
  49. O'Neal S, Hedberg K, Markum A, Schafer S. Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers. Int J Tuberc Lung Dis 2009;13:662-4
  50. Olivier C. Tuberculosis: diagnosis of contact persons and chemoprophylaxis in children. Arch Pediatr 2003;10:847-52 https://doi.org/10.1016/S0929-693X(03)00386-5
  51. Rieder HL. Contacts of tuberculosis patients in high-incidence countries. Int J Tuberc Lung Dis 2003;7 Suppl 3: S333-6
  52. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. C : WHO, 2008;135-9
  53. Stevens JP, Daniel TM. Chemoprophylaxis of multidrug- resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide: a decision analysis. Chest 1995;108:712-7 https://doi.org/10.1378/chest.108.3.712
  54. Passannante MR, Gallagher CT, Reichman LB. Preventive therapy for contacts of multidrug-resistant tuberculosis: a Delphi survey. Chest 1994;106:431-4 https://doi.org/10.1378/chest.106.2.431
  55. Horn DL, Hewlett D Jr, Alfalla C, Peterson S, Opal SM. Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis. N Engl J Med 1994;330:1241 https://doi.org/10.1056/NEJM199404283301718
  56. Schaaf HS, Gie RP, Kennedy M, Beyers N, Hesseling PB, Donald PR. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30- month follow-up. Pediatrics 2002;109;765-71 https://doi.org/10.1542/peds.109.5.765
  57. Takizawa T, Hashimoto K,Minami T, Yamashita S, Owen K. The comparative arthropathy of fluoroquinolones in dogs. Hum Exp Toxicol 1999;18:392-9 https://doi.org/10.1191/096032799678840237
  58. Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J 1997;16:127-9 https://doi.org/10.1097/00006454-199701000-00036

Cited by

  1. 초등교사의 결핵 예방행위와 영향요인 vol.12, pp.3, 2009, https://doi.org/10.12811/kshsm.2018.12.3.157